Luis Izquierdo

Dr. Luis Izquierdo

orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 January 2018 in The Lancet Infectious Diseases
Verified
Journal Article
Closed access
FTFaustino Torrico
Faustino Torrico
JGJoaquim Gascon
Joaquim Gascon
LOLourdes Ortiz
Lourdes Ortiz
CACristina Alonso-Vega
Cristina Alonso-Vega
Maria Jesús PinazoMaria Jesús Pinazo
Maria Jesús Pinazo
WJWladimiro Jimenez
Wladimiro Jimenez

6 August 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
NONatalia Ortega
Natalia Ortega
MRMarta Ribes
Marta Ribes
MVMarta Vidal
Marta Vidal
RRRocío Rubio
Rocío Rubio
RARuth Aguilar
Ruth Aguilar
CDCarlota Dobaño
Carlota Dobaño
Unraveling the long-term kinetics of antibodies to SARS-CoV-2 and the individual characteristics influencing it, including the impact of pre-existing antibodies to human coronaviruses causing common cold (HCoVs), is essential to understand protective immunity to COVID-19 and devise effective surveillance strategies. IgM, IgA and IgG levels against six SARS-CoV-2 antigens and the nucleocapsid antigen of the four HCoV (229E, NL63, OC43 and HKU1) were quantified by Luminex, and antibody neutralization capacity was assessed by flow cytometry, in a cohort of health care workers followed up to 7 months (N = 578). Seroprevalence increases over time from 13.5% (month 0) and 15.6% (month 1) to 16.4% (month 6). Levels of antibodies, including those with neutralizing capacity, are stable over time, except IgG to nucleocapsid antigen and IgM levels that wane. After the peak response, anti-spike antibody levels increase from ~150 days post-symptom onset in all individuals (73% for IgG), in the absence of any evidence of re-exposure. IgG and IgA to HCoV are significantly higher in asymptomatic than symptomatic seropositive individuals. Thus, pre-existing cross-reactive HCoVs antibodies could have a protective effect against SARS-CoV-2 infection and COVID-19 disease.

23 July 2009 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
LILuis Izquierdo
Luis Izquierdo
BSBenjamin Schulz
Benjamin Schulz
JRJoão A Rodrigues
João A Rodrigues
MGMaria Lucia S Güther
Maria Lucia S Güther
JPJames B Procter
James B Procter
MFMichael A J Ferguson
Michael A J Ferguson
Asparagine-linked glycosylation is catalysed by oligosaccharyltransferase (OTase). In Trypanosoma brucei OTase activity is catalysed by single-subunit enzymes encoded by three paralogous genes of which TbSTT3B and TbSTT3C can complement a yeast Deltastt3 mutant. The two enzymes have overlapping but distinct peptide acceptor specificities, with TbSTT3C displaying an enhanced ability to glycosylate sites flanked by acidic residues. TbSTT3A and TbSTT3B, but not TbSTT3C, are transcribed in the bloodstream and procyclic life cycle stages of T. brucei. Selective knockdown and analysis of parasite protein N-glycosylation showed that TbSTT3A selectively transfers biantennary Man(5)GlcNAc(2) to specific glycosylation sites whereas TbSTT3B selectively transfers triantennary Man(9)GlcNAc(2) to others. Analysis of T. brucei glycosylation site occupancy showed that TbSTT3A and TbSTT3B glycosylate sites in acidic to neutral and neutral to basic regions of polypeptide, respectively. This embodiment of distinct specificities in single-subunit OTases may have implications for recombinant glycoprotein engineering. TbSTT3A and TbSTT3B could be knocked down individually, but not collectively, in tissue culture. However, both were independently essential for parasite growth in mice, suggesting that inhibiting protein N-glycosylation could have therapeutic potential against trypanosomiasis.

1 September 2009 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
SPSonia Paytubi
Sonia Paytubi
XWXuemin Wang
Xuemin Wang
YLYun W. Lam
Yun W. Lam
LILuis Izquierdo
Luis Izquierdo
MHMairi J. Hunter
Mairi J. Hunter
CPChristopher Proud
Christopher Proud
ABC50 is an ATP-binding cassette (ABC) protein, which, unlike most ABC proteins, does not possess membrane-spanning domains. ABC50 interacts with eukaryotic initiation factor 2 (eIF2), which plays a key role in translation initiation and its control. ABC50 binds to ribosomes, and this interaction requires both the N-terminal domain and at least one ABC domain. Knockdown of ABC50 by RNA interference impaired translation of both cap-dependent and -independent reporters, consistent with a positive role for ABC50 in the function of eIF2, which is required for both types of translation initiation. Mutation of the Walker box A or B motifs in both ABC regions of ABC50 yielded a mutant protein that exerted a dominant-interfering phenotype with respect to protein synthesis and translation initiation. Importantly, although dominant-interfering mutants of ABC50 impaired cap-dependent translation, translation driven by certain internal ribosome entry segments was not inhibited. ABC50 is located in the cytoplasm and nucleoplasm but not in the nucleolus. Thus, ABC50 is not likely to be directly involved in early ribosomal biogenesis, unlike some other ABC proteins. Taken together, the present data show that ABC50 plays a key role in translation initiation and has functions that are distinct from those of other non-membrane ABC proteins.

1 January 2004 in Infection and Immunity
Verified
Journal Article
Open access
PDF file
MRMiguel Regué
Miguel Regué
BHBeatriz Hita
Beatriz Hita
NPnuria pique
nuria pique
LILuis Izquierdo
Luis Izquierdo
Susana MerinoSusana Merino
Susana Merino
Juan TomasJuan Tomas
Juan Tomas
Klebsiella pneumoniae strains typically express both smooth lipopolysaccharide (LPS) with O antigen molecules and capsule polysaccharide (K antigen) on the surface. A single mutation in a gene that codes for a UDP galacturonate 4-epimerase (uge) renders a strain with the O−:K− phenotype (lack of capsule and LPS without O antigen molecules and outer core oligosaccharide). The uge gene was present in all the K. pneumoniae strains tested. The K. pneumoniae uge mutants were unable to produce experimental urinary tract infections in rats and were completely avirulent in two different animal models (septicemia and pneumonia). Reintroduction of the single uge wild-type gene in the corresponding mutants completely restored the wild-type phenotype (presence of capsule and smooth LPS) independently of the O or K serotype of the wild type. Furthermore, complemented uge mutants recovered the ability to produce experimental urinary tract infections in rats and virulence in the septicemia and pneumonia animal models.

15 December 2003 in Journal of Bacteriology
Verified
Journal Article
Open access
PDF file
LILuis Izquierdo
Luis Izquierdo
NCNúrIa Coderch
NúrIa Coderch
NPnuria pique
nuria pique
EBEmiliano Bedini
Emiliano Bedini
Maria Michela CorsaroMaria Michela Corsaro
Maria Michela Corsaro
MRMiguel Regué
Miguel Regué
To determine the function of the wabG gene in the biosynthesis of the core lipopolysaccharide (LPS) of Klebsiella pneumoniae , we constructed wabG nonpolar mutants. Data obtained from the comparative chemical and structural analysis of LPS samples obtained from the wild type, the mutant strain, and the complemented mutant demonstrated that the wabG gene is involved in attachment toα - l -glycero- d -manno-heptopyranose II ( l , d -Hep p II) at the O-3 position of anα - d -galactopyranosyluronic acid (α- d -GalA p ) residue. K. pneumoniae nonpolar wabG mutants were devoid of the cell-attached capsular polysaccharide but were still able to produce capsular polysaccharide. Similar results were obtained with K. pneumoniae nonpolar waaC and waaF mutants, which produce shorter LPS core molecules than do wabG mutants. Other outer core K. pneumoniae nonpolar mutants in the waa gene cluster were encapsulated. K. pneumoniae waaC , waaF , and wabG mutants were avirulent when tested in different animal models. Furthermore, these mutants were more sensitive to some hydrophobic compounds than the wild-type strains. All these characteristics were rescued by reintroduction of the waaC , waaF , and wabG genes from K. pneumoniae .